Healthcare provider profile · identity verified

Timothy Griffiths, CNP

Nurse Practitioner · CANTON, OH · NPI 1215380019

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	467	58
Furosemide	Furosemide	433	72
Tramadol Hcl	Tramadol Hcl	308	56
Buspirone Hcl	Buspirone Hcl	241	46
Potassium Chloride	Potassium Chloride	221	25
Metoprolol Tartrate	Metoprolol Tartrate	217	28
Lorazepam	Lorazepam	216	51
Pantoprazole Sodium	Pantoprazole Sodium	193	25
Atorvastatin Calcium	Atorvastatin Calcium	188	26
Gabapentin	Gabapentin	177	25
Amlodipine Besylate	Amlodipine Besylate	162	23
Eliquis	Apixaban	160	28
Warfarin Sodium	Warfarin Sodium	159	suppressed
Omeprazole	Omeprazole	158	17
Jardiance	Empagliflozin	148	14
Mirtazapine	Mirtazapine	147	30
Sertraline Hcl	Sertraline Hcl	146	26
Trazodone Hcl	Trazodone Hcl	144	29
Tamsulosin Hcl	Tamsulosin Hcl	142	18
Metformin Hcl	Metformin Hcl	130	24
Donepezil Hcl	Donepezil Hcl	125	16
Methenamine Hippurate	Methenamine Hippurate	123	15
Lisinopril	Lisinopril	122	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	27
Losartan Potassium	Losartan Potassium	119	16
Metoprolol Succinate	Metoprolol Succinate	114	15
Clonazepam	Clonazepam	103	14
Memantine Hcl	Memantine Hcl	93	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	91	27
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	86	52
Alprazolam	Alprazolam	81	18
Pregabalin	Pregabalin	80	15
Hydrochlorothiazide	Hydrochlorothiazide	78	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	77	48
Pravastatin Sodium	Pravastatin Sodium	77	12
Ropinirole Hcl	Ropinirole Hcl	75	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	73	suppressed
Nystatin	Nystatin	66	38
Prednisone	Prednisone	64	suppressed
Ibuprofen	Ibuprofen	57	20
Carvedilol	Carvedilol	53	suppressed
Simvastatin	Simvastatin	53	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	50	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	13
Loperamide	Loperamide Hcl	48	21
Meloxicam	Meloxicam	46	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	45	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	44	suppressed
Alendronate Sodium	Alendronate Sodium	43	suppressed
Bumetanide	Bumetanide	43	suppressed
Valsartan	Valsartan	42	suppressed
Amiodarone Hcl	Amiodarone Hcl	41	suppressed
Cephalexin	Cephalexin	41	30
Atenolol	Atenolol	39	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	25
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Lacosamide	Lacosamide	35	suppressed
Primidone	Primidone	35	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Risperidone	Risperidone	34	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Divalproex Sodium	Divalproex Sodium	31	suppressed
Metolazone	Metolazone	30	suppressed
Repaglinide	Repaglinide	30	suppressed
Cimetidine	Cimetidine	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Methylprednisolone	Methylprednisolone	27	22
Ramipril	Ramipril	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Baclofen	Baclofen	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	14
Xarelto	Rivaroxaban	24	suppressed
Cholestyramine	Cholestyramine (With Sugar)	23	suppressed
Famotidine	Famotidine	23	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Budesonide Dr	Budesonide	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Nyamyc	Nystatin	21	15
Allopurinol	Allopurinol	20	suppressed
Calcitriol	Calcitriol	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Fenofibrate	Fenofibrate,micronized	19	suppressed
Levemir Flexpen	Insulin Detemir	19	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	19	16
Lovastatin	Lovastatin	18	suppressed
Azithromycin	Azithromycin	17	15
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	12
Amoxicillin	Amoxicillin	16	11
Easy Touch Pen Needle	Pen Needle, Diabetic	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Admelog Solostar	Insulin Lispro	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Torsemide	Torsemide	14	suppressed
Humira(Cf) Pen	Adalimumab	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Phenytoin	Phenytoin	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Galantamine Er	Galantamine Hbr	12	suppressed
Glipizide	Glipizide	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	12	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	12	suppressed
Linzess	Linaclotide	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Olanzapine	Olanzapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error